Canadian nod for Aurobindo's Hyderabad units

Aurobindo Pharma has received Canadian regulatory authority's approval for Unit III for oral solid dosage forms and Unit VI for sterile and non-sterile cephalosporin dosage forms. Health Canada has approved the aforementioned sites.

According to a release issued by Aurobindo Pharma to the BSE, the company's Unit III at Hyderabad has four production blocks and is dedicated to products other than cephalosporins / penicillin's oral dosage formulations. In addition, it holds ISO and approvals from several other countries.

The release further stated that Unit VI oral dosage formulations is also approved by US FDA, MCC- South Africa, Brazilian ANVISA and many other regulatory agencies apart from Canadian authority, and is located near Hyderabad, Andhra Pradesh.